News

ISN Journal summaries on the DIALIZE-Outcomes trial and heat stress nephropathy in CKDu hotspots in India 

Kidney International®   The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis  People on hemodialysis often face dangerous swings in blood potassium that can trigger sudden death or heart rhythm problems.   The DIALIZE-Outcomes trial tested whether the potassium binder sodium zirconium cyclosilicate (SZC) could reduce serious cardiovascular events compared with placebo in 2,690 patients with kidney failure.  The...

October 13, 2025Journals, News, ResearchRead more...

From page to stage: Apply for a 2025 KI-ISN Early-Career Researcher Award 

Was your original research published in Kidney International® in 2025?   Here’s a chance to have your work showcased at the World Congress of Nephrology 2026 in Yokohama, Japan — and receive $500!   Find out more and apply by December 5   Who can apply for a KI-ISN Early-Career Researcher Award?     First authors of original research papers (clinical or basic/translational...

October 13, 2025Awards, NewsRead more...

Build an early CKD detection program, one building block at a time 

Early detection of CKD can save lives and reduce healthcare costs by slowing progression, preventing complications, and avoiding costly dialysis or transplantation. Utilize the Starting and Sustaining Early CKD Detection and Intervention Programs Toolbox to address CKD detection gaps rand help improve care for those at risk.  Designed as a set of building blocks, the...

October 13, 2025Initiatives, ISN Toolkits, NewsRead more...

“Straightforward to detect and treat”: Marcello Tonelli on preventing kidney disease — watch the recording

"Kidney disease is straightforward to detect and straightforward to treat in primary care, if you provide people with the right tools and the right support." That was the message from ISN President Marcello Tonelli during "Kidney Health Matters: Advancing Commitments into Action," a high-level event co-hosted by the ISN and Devex on the sidelines...

October 13, 2025Advocacy, NewsRead more...

ISN launches implementation strategy in response to WHO kidney resolution

October 13, 2025, Building on the momentum of the first-ever WHO kidney health resolution adopted earlier this year, the ISN is launching an implementation strategy that aims toward translating global commitments into practical measures at the national level. ISN President Marcello Tonelli stated, “The ISN will lead dialogue and provide resources and expertise to support countries...

October 13, 2025NewsRead more...

Putting patients first: New video series on kidney supportive care

People living with kidney disease and their families face difficult choices and uncertainty, highlighting the need for clear, compassionate guidance about treatment options. To support them, the ISN has developed an open-access video series to help patients and families understand supportive care, make informed choices, and access person-centered care throughout their kidney journey.  Explore the...

October 13, 2025Education, NewsRead more...

Better outcomes for interconnected conditions: The ISN’s CKM Initiative on World Heart Day 

As we observe World Heart Day, today, September 29, the ISN underscores the critical intersection of cardiovascular and kidney health through its Cardio-Kidney-Metabolic (CKM) Initiative.   The ISN encourages healthcare professionals worldwide to integrate the CKM tools into their practice. By doing so, clinicians can refine their approach to treating patients with overlapping cardiovascular, kidney, and...

September 29, 2025Initiatives, ISN Toolkits, NewsRead more...

ISN around the world: Celebrating excellence and education 

ISN leaders are spotlighting global kidney health throughout October. Whether sharing the latest research, building partnerships, or amplifying regional voices, these engagements help elevate the global conversation on equitable kidney care.  Where to find the ISN this October  October 7-10   10th Annual Congress of the SFNDT Touraine, France  At the congress of the Société Francophone de Néphrologie, Dialyse...

September 29, 2025ISN Participates, NewsRead more...

New at WCN’26: Courses now included in the congress registration fee!* 

The WCN'26 program on Saturday, March 28, 2026, offers interactive courses designed to sharpen skills, deepen knowledge, and enhance patient care.     Explore WCN’26 courses  Register for WCN'26 at early bird rates  Submit your abstract    Cancer and Kidney Disease: The Growing Intersection of Their Genesis and Treatment Gain an up-to-date overview of onco-nephrology through expert-led, case-based sessions. This clinically focused...

September 29, 2025News, WCNRead more...

Early-career nephrologists deepen expertise in glomerular disease at ISN course in Prague  

As part of its commitment to strengthening global kidney care, the ISN hosted its latest “Primer Course in Glomerular Diseases” in Prague, Czech Republic, in September 2025.  One participant commented, “It was fun, interesting, and relevant to daily clinical practice. I have definitely gained more confidence in the diagnosis and management of glomerular diseases.”  Over two...

September 29, 2025Education, Events, NewsRead more...

Continuing to advocate for global recognition of kidney health 

At the fourth high-level meeting of the 80th session of the United Nations General Assembly (UNGA80) on the prevention and control of noncommunicable diseases (NCDs) and the promotion of mental health and wellbeing, governments from around the world reaffirmed their shared commitment to tackling the world’s leading causes of death and disability.  Although there has...

September 29, 2025Advocacy, News, WHORead more...

Supporting patients with rare kidney diseases: ISN fact sheet now in multiple languages 

Designed as an advocacy resource, the ISN fact sheet on rare kidney diseases (RKDs) was first launched in English at the 78th World Health Assembly. Now available in several languages, the ISN encourages all members and partners to leverage this tool in their advocacy, policymaking, and clinical engagement efforts.  Arabic  Chinese   French  Japanese  Spanish  Access the translated fact sheets*  The fact...

September 29, 2025Initiatives, ISN Toolkits, NewsRead more...

ISN Journal summaries on the KDIGO Guideline on IgAN and IgAV, and urinary dickkopf-3 to predict GFR loss 

Kidney International®   KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)  IgA nephropathy and IgA vasculitis are leading causes of kidney disease worldwide, but treatment approaches have long varied.   The KDIGO 2025 guideline consolidates the latest evidence to provide updated recommendations on diagnosis, risk assessment, and therapies, aiming...

September 29, 2025Journals, NewsRead more...

Countdown to World Kidney Day 2026: Year-long campaign starts now! 

The annual World Kidney Day (WKD) campaign for 2026 officially launched today, September 15. This year-long campaign will culminate in a global day of activities on Thursday March 12, 2026.  The 2026 campaign carries the powerful message, “Kidney health for all: Caring for people, protecting the planet,” highlighting the vital link between kidney care and...

September 15, 2025Advocacy, News, World Kidney DayRead more...

Shaping the future of transplantation with AI: Listen to the ISN Podcast 

This episode of the ISN Global Kidney Care Podcast explores how artificial intelligence (AI) is transforming kidney transplantation — from overcoming clinical challenges to tackling disparities in access and unlocking the potential of generative AI to manage unstructured medical data.  Listen to this episode of the Global Kidney Care Podcast   “We fitted … a kind of...

September 15, 2025Education, NewsRead more...

WCN’26 plenary: Dennis Lo on diagnostic breakthroughs with liquid biopsy  

  Dennis Lo, Li Ka Shing professor of medicine and professor of chemical pathology at the Chinese University of Hong Kong, will deliver a WCN’26 plenary on “Creating paradigm shifts in medical diagnostics using liquid biopsy”, exploring how this technology is reshaping diagnostics and its implications for kidney care.  WCN’26 registration opens tomorrow!  Explore the WCN’26 preliminary...

September 15, 2025News, WCNRead more...

Stand out and avoid pitfalls: Tips for abstract submitters 

        WCN Abstract Working Group co-chairs Alessia Fornoni (left) and Bianca Davidson  According to WCN Abstract Working Group co-chair* Alessia Fornoni, WCN is "designed to promote 'bedside to research and back' networking opportunities with a global impact." Submitting an abstract is therefore not only about presenting results but also about:  Gaining visibility  Building connections  Receiving valuable feedback from...

September 15, 2025News, WCNRead more...

POCUS training in Islamabad: Enhancing real-time clinical decisions for nephrologists

    Trainee and senior registrars, consultants, and associate professors participated in the course    ISN Educational Ambassador Saeed Ahmed* recently visited the Khan Research Laboratory Hospital (KRL) in Islamabad, Pakistan, to deliver a comprehensive point-of-care ultrasound (POCUS) course for nephrologists with participants from several different institutions and specialties within the country.  Professor Ahmed presents at the training...

September 15, 2025Educational Ambassador, Grants, NewsRead more...

CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes  

ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes the design and outcomes of the latest “Trial of the month” featured in ISN-ACT GTF.  Trial of the month:  Stronger together: Finerenone & empagliflozin boost kidney outcomes in diabetes  Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes  Agarwal R, et al., N Engl J...

September 15, 2025News, ResearchRead more...

ISN Journal summaries on zigakibart, proteinuria, and pediatric CKD in rural Africa 

Kidney International®   Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy  Zigakibart, a humanized monoclonal antibody targeting A Proliferation-Inducing Ligand (APRIL), was tested in healthy volunteers and patients with IgA nephropathy (IgAN) in a Phase 1/2 trial with 100-week follow-up.   The treatment was well tolerated and led...

September 15, 2025Journals, NewsRead more...